BlackRock Institutional Trust’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

BlackRock Institutional Trust’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.73M	Buy	771,350 +31,164	+4%	+$925K	﹤0.01%	2828
2016 Q3	$34.1M	Buy	740,186 +24,401	+3%	+$1.38M	0.01%	1524
2016 Q2	$36.5M	Buy	715,785 +51,972	+8%	+$2.58M	0.01%	1435
2016 Q1	$28.1M	Buy	663,813 +14,043	+2%	+$716K	﹤0.01%	1586
2015 Q4	$51M	Buy	649,770 +42,436	+7%	+$2.45M	0.01%	1229
2015 Q3	$24.6M	Buy	607,334 +268,651	+79%	+$14.2M	﹤0.01%	1690
2015 Q2	$17.6M	Buy	338,683 +166,301	+96%	+$8.27M	﹤0.01%	2006
2015 Q1	$8.02M	Buy	172,382 +27,700	+19%	+$1.44M	﹤0.01%	2531
2014 Q4	$6.49M	Sell	144,682 -1,941	-1%	-$81.5K	﹤0.01%	2610
2014 Q3	$5.71M	Sell	146,623 -12,296	-8%	-$483K	﹤0.01%	2632
2014 Q2	$6.72M	Buy	158,919 +61,816	+64%	+$2.27M	﹤0.01%	2634
2014 Q1	$3.46M	Sell	97,103 -47,355	-33%	-$1.6M	﹤0.01%	2930
2013 Q4	$4.67M	Buy	+144,458	New	+$4.29M	﹤0.01%	2819

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock Institutional Trust's ISEE Position: Q4 2016 in Review

BlackRock Institutional Trust increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 4.2% in Q4 2016, buying an estimated $925K and bringing the position to 771,350 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

BlackRock Institutional Trust first reported a position in ISEE in Q4 2013 and has held it in 13 quarters since. The position peaked at $51M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

BlackRock Institutional Trust held 771,350 shares of IVERIC bio, Inc. Common Stock worth $3.73M as of Q4 2016.
BlackRock Institutional Trust bought 31,164 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $925K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2828 holding.
BlackRock Institutional Trust first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
BlackRock Institutional Trust's IVERIC bio, Inc. Common Stock position peaked at $51M in Q4 2015.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.